Business Context and Reporting Period
This Form 8-K Current Report was filed by MYOMO, INC. on April 14, 2026, with the report date finalized on April 16, 2026. The filing discloses a corporate governance change involving the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and board composition.
Material Changes
The primary material change reported is the appointment of William J. Febbo to the Board of Directors, effective April 14, 2026. Key details include:
- Role: Class II Director (term expires at the 2028 annual meeting).
- Background: Currently CEO of Performance Health Systems (joined Feb 2026); former CEO of OptimizeRx Corporation (2015–2024).
- Committee Assignments: None at this time.
Compensation and Management Commentary
In connection with his appointment, Mr. Febbo received the following compensatory arrangements:
- Restricted Stock Units (RSUs): 45,000 RSUs granted, vesting in full on the first anniversary of the appointment.
- Cash Retainer: $60,000 annually.
- Equity Retainer: $85,000 annually paid in RSUs, vesting over four quarters.
The Company issued a press release on April 16, 2026, regarding this appointment (Exhibit 99.1). No other risks, contingencies, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the vesting schedule and fair value of the 45,000 initial RSUs and the $85,000 annual equity retainer.
- Confirm Mr. Febbo's current status and role at Performance Health Systems to assess potential conflicts of interest.
- Review the full text of the April 16, 2026 press release (Exhibit 99.1) for additional strategic context not included in the 8-K summary.
- Check subsequent filings for any committee assignments or changes to Mr. Febbo's term.